Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amyris Inc (NQ: AMRS )

0.9199 -0.0301 (-3.17%)
Streaming Delayed Price Updated: 3:03 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Amyris Inc

MarketBeat Week in Review – 4/17 - 4/21
Markets ended the week on a down note as further evidence that the markets are likely to continue to bounce around but could get a jolt from earnings next week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Amyris May be Oversold, but is it Worth Fighting the Shorts?
Amyris is fighting a battle with short sellers, and with the economy either in, or nearing, a recession, there may be better options for speculative investors 
Via MarketBeat
Topics Economy
Exposures Economy
MarketBeat Podcast, 3 Small Caps With Big Upside
Today on The MarketBeat Podcast is Randy Baron, portfolio manager at Pinnacle Associates. Three stocks Randy discusses today have small market capitalizations. 
Via MarketBeat
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
Synthetic biology maker Amyris owns a 60% global market share for a product that's increasingly used in personal care products. Will it notch a profit in 2024? 
Via MarketBeat
Global Plant Based Protein Market Expected To Reach $40 Billion by 2027
Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – The pandemic has considerably transformed consumer buying patterns, with a steady shift being witnessed toward health-improving... 
Via FinancialNewsMedia
Federman & Sherwood Announces Certification of Securities Class Action Lawsuit Against Amyris, Inc.
From Federman & Sherwood
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.